A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection

Recruiting

Phase 2

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Code:

NCT05582694

Conditions

Multi-Drug Resistant Hiv-1 Infection

HIV-1 Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

UB-421

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information